BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,056 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $925,951 | -14.7% | 24,535 | +3.0% | 0.01% | -11.1% |
Q2 2023 | $1,085,513 | +108560.0% | 23,826 | -3.3% | 0.01% | 0.0% |
Q1 2023 | $999 | -30.5% | 24,636 | -12.7% | 0.01% | -30.8% |
Q4 2022 | $1,438 | -99.9% | 28,210 | +2.2% | 0.01% | -13.3% |
Q3 2022 | $1,486,000 | -24.8% | 27,591 | -10.4% | 0.02% | -21.1% |
Q2 2022 | $1,977,000 | -17.7% | 30,777 | -0.6% | 0.02% | 0.0% |
Q1 2022 | $2,401,000 | -8.5% | 30,956 | +1.2% | 0.02% | -5.0% |
Q4 2021 | $2,625,000 | +15.7% | 30,580 | +8.4% | 0.02% | 0.0% |
Q3 2021 | $2,268,000 | -10.4% | 28,198 | -10.3% | 0.02% | -9.1% |
Q2 2021 | $2,530,000 | -4.8% | 31,430 | -0.3% | 0.02% | -8.3% |
Q1 2021 | $2,658,000 | 0.0% | 31,519 | -4.8% | 0.02% | -7.7% |
Q4 2020 | $2,658,000 | -1.3% | 33,121 | -1.1% | 0.03% | -10.3% |
Q3 2020 | $2,693,000 | -18.6% | 33,489 | -12.9% | 0.03% | -25.6% |
Q2 2020 | $3,310,000 | +4.6% | 38,444 | -1.3% | 0.04% | -7.1% |
Q1 2020 | $3,163,000 | -2.5% | 38,950 | +0.4% | 0.04% | +23.5% |
Q4 2019 | $3,244,000 | -6.0% | 38,800 | -1.6% | 0.03% | -10.5% |
Q3 2019 | $3,450,000 | +11.7% | 39,444 | +4.6% | 0.04% | +8.6% |
Q2 2019 | $3,088,000 | -1.0% | 37,707 | -1.7% | 0.04% | -2.8% |
Q1 2019 | $3,120,000 | +20.1% | 38,365 | -2.8% | 0.04% | +12.5% |
Q4 2018 | $2,598,000 | -18.0% | 39,467 | -3.9% | 0.03% | -5.9% |
Q3 2018 | $3,167,000 | +0.4% | 41,074 | -3.8% | 0.03% | -5.6% |
Q2 2018 | $3,153,000 | +16.6% | 42,710 | +2.7% | 0.04% | +20.0% |
Q1 2018 | $2,705,000 | -3.2% | 41,599 | -3.8% | 0.03% | 0.0% |
Q4 2017 | $2,795,000 | +1.3% | 43,237 | -1.7% | 0.03% | -3.2% |
Q3 2017 | $2,760,000 | +0.1% | 43,987 | -3.4% | 0.03% | -3.1% |
Q2 2017 | $2,756,000 | +12.7% | 45,521 | -3.5% | 0.03% | +10.3% |
Q1 2017 | $2,445,000 | +5.2% | 47,151 | -10.1% | 0.03% | +3.6% |
Q4 2016 | $2,324,000 | -12.3% | 52,426 | -5.9% | 0.03% | -17.6% |
Q3 2016 | $2,651,000 | -4.3% | 55,697 | -9.1% | 0.03% | -5.6% |
Q2 2016 | $2,771,000 | -2.7% | 61,264 | -11.6% | 0.04% | -5.3% |
Q1 2016 | $2,848,000 | +4.9% | 69,308 | -2.6% | 0.04% | +5.6% |
Q4 2015 | $2,715,000 | +11.0% | 71,167 | -4.4% | 0.04% | +2.9% |
Q3 2015 | $2,445,000 | -59.1% | 74,428 | -13.0% | 0.04% | -55.7% |
Q2 2015 | $5,981,000 | -8.9% | 85,529 | -10.8% | 0.08% | -6.0% |
Q1 2015 | $6,566,000 | -15.3% | 95,851 | -9.4% | 0.08% | -16.0% |
Q4 2014 | $7,750,000 | -24.8% | 105,741 | -26.4% | 0.10% | -22.5% |
Q3 2014 | $10,308,000 | -16.1% | 143,632 | -15.4% | 0.13% | -14.0% |
Q2 2014 | $12,282,000 | -23.2% | 169,876 | -21.8% | 0.15% | -26.1% |
Q1 2014 | $15,982,000 | -31.2% | 217,200 | -35.0% | 0.20% | -29.3% |
Q4 2013 | $23,229,000 | -53.4% | 333,990 | -56.0% | 0.29% | -56.4% |
Q3 2013 | $49,874,000 | -1.6% | 759,234 | +3.7% | 0.66% | -4.6% |
Q2 2013 | $50,708,000 | – | 732,030 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |